Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

finance.yahoo.com/news/merck-co-mrk-rsv-antibody-153004423.html

In This Article:
Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA). This shot shields infants up to the age of one from the respiratory…

This story appeared on finance.yahoo.com, 2025-06-11 15:30:04.
The Entire Business World on a Single Page. Free to Use →